Esperion Therapeutics, Inc.

NasdaqGM:ESPR Stock Report

Market Cap: US$193.3m

Esperion Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:ESPR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Apr 25SellUS$106Eric WarrenIndividual108US$0.98
17 Apr 25SellUS$8Benjamin HalladayIndividual8US$0.96
18 Mar 25SellUS$3,618Eric WarrenIndividual2,433US$1.49
18 Mar 25SellUS$5,242Benjamin HalladayIndividual3,535US$1.48
18 Mar 25SellUS$19,623Sheldon KoenigIndividual13,047US$1.50
19 Feb 25SellUS$20Benjamin HalladayIndividual11US$1.86
19 Feb 25SellUS$446Eric WarrenIndividual239US$1.87
17 Jan 25SellUS$278Eric WarrenIndividual123US$2.26
17 Jan 25SellUS$20Benjamin HalladayIndividual9US$2.27
17 Dec 24SellUS$5,426Eric WarrenIndividual2,234US$2.43
17 Dec 24SellUS$7,866Benjamin HalladayIndividual3,245US$2.42
17 Dec 24SellUS$30,694Sheldon KoenigIndividual12,447US$2.47
19 Nov 24SellUS$427Eric WarrenIndividual197US$2.17
17 Oct 24SellUS$227Eric WarrenIndividual107US$2.12
17 Sep 24SellUS$4,650Eric WarrenIndividual2,608US$1.78
17 Sep 24SellUS$26,132Sheldon KoenigIndividual14,550US$1.80
19 Aug 24SellUS$411Eric WarrenIndividual211US$1.95
17 Jul 24SellUS$2,383JoAnne FoodyIndividual917US$2.60
17 Jul 24SellUS$279Eric WarrenIndividual108US$2.59
18 Jun 24SellUS$7,254Eric WarrenIndividual2,540US$2.86
18 Jun 24SellUS$9,418JoAnne FoodyIndividual3,285US$2.87
17 May 24SellUS$477Eric WarrenIndividual192US$2.48

Insider Trading Volume

Insider Buying: ESPR insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of ESPR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,553,6110.784%
General Public78,277,58939.5%
Institutions118,318,22159.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 51.65% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.31%
BlackRock, Inc.
14,493,020US$14.1m1.81%no data
5.91%
The Vanguard Group, Inc.
11,715,748US$11.4m-10.2%no data
5.52%
Wasatch Advisors LP
10,931,257US$10.7m-55.4%0.04%
4.89%
Bellevue Asset Management AG
9,694,064US$9.5m-2.51%0.15%
3.14%
Two Seas Capital LP
6,230,871US$6.1m-5.37%0.93%
3.11%
Morgan Stanley, Investment Banking and Brokerage Investments
6,164,037US$6.0m146%no data
2.27%
State Street Global Advisors, Inc.
4,504,234US$4.4m16.9%no data
2.19%
Geode Capital Management, LLC
4,339,948US$4.2m0.2%no data
1.91%
Meditor Group Ltd.
3,791,300US$3.7m0%2.48%
1.82%
Two Sigma Advisers, LP
3,616,200US$3.5m0.45%0.01%
1.79%
Two Sigma Investments, LP
3,540,361US$3.5m-2.34%0.01%
1.57%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
3,110,603US$3.0m48.6%no data
1.51%
Indaba Capital Management, L.P.
3,000,000US$2.9m0%7.57%
1.33%
Goldman Sachs Group, Investment Banking and Securities Investments
2,639,858US$2.6m0%no data
0.97%
Rhenman & Partners Asset Management AB
1,915,000US$1.9m-3.04%0.17%
0.89%
Citadel Advisors LLC
1,754,632US$1.7m1,210%no data
0.82%
Bank of America Corporation, Asset Management Arm
1,620,335US$1.6m46%no data
0.78%
Northern Trust Global Investments
1,540,084US$1.5m4.45%no data
0.76%
Woodline Partners LP
1,503,746US$1.5m-33%0.01%
0.66%
Centerbook Partners LP
1,306,259US$1.3m-58%0.09%
0.61%
JP Morgan Asset Management
1,202,736US$1.2m-11.3%no data
0.54%
JPMorgan Chase & Co, Brokerage and Securities Investments
1,072,885US$1.0m105%no data
0.47%
Connor, Clark & Lunn Investment Management Ltd.
932,008US$909.2k31%no data
0.44%
UBS Asset Management AG
876,942US$855.5k871%no data
0.42%
Kieger AG
842,060US$821.4k0%0.29%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/07 04:54
End of Day Share Price 2025/05/07 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Esperion Therapeutics, Inc. is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason ZemanskyBofA Global Research
Kristen KluskaCantor Fitzgerald & Co.
Jason ButlerCitizens JMP Securities, LLC